Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00260559 · ClinicalTrials.gov registry record
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
A clinical trial of Esophageal Cancer and Esophagectomy, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- 3,500
- Enrollment target
- 2
- Study locations
NCT00260559: Recruiting study of Esophageal Cancer and Esophagectomy, sponsored by University of Pittsburgh.
NCT00260559 is a study of Esophageal Cancer and Esophagectomy that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 3,500 participants, above the 471-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (643% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00260559, a study of Esophageal Cancer and Esophagectomy, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- 3,500 participants
- Enrollment target
- 2
- Study locations
Study Summary
To assess short and long term outcomes after minimally invasive esophagectomy compared to open esophagectomy. To compare both standard outcome measures as well as patient derived outcome measures, in particular, quality of life (QOL). To look at the applicability of this QOL instrument to this patient group.
Primary Outcome
The SF36 is an eight dimension Quality of Life Measurement. It provides two main Component scores, Physical Component Summary (PCS) and the Mental Component Summary (MCS). It includes 8 scales or sub-scores: Physical function (PF), role physical (RP), Bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MG). Each scale contributes a different amount to the component scores, which are calculated by a special algorithm that is licen
Conditions Studied
Interventions
- PROCEDURE Questionnaires
Study Locations (2)
Pennsylvania
- University of Pittsburgh Medical Center - Department of Cardiothoracic Surgery - Pittsburgh
- UPMC - Hillman Cancer Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,500 participants |
| Start Date | 1999-05 |
| Est. Completion | 2050-12 |
What NCT00260559 shows while recruiting
NCT00260559 is an observational study that tracks outcomes without assigning an intervention. Its 3,500 participants enrollment target places it among the larger protocols in the corpus, above the 471-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (643% higher).
The record links to 2 conditions, with Esophageal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Questionnaires is the first listed.
NCT00260559 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00260559 about?
NCT00260559 is a clinical study titled "Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life". To assess short and long term outcomes after minimally invasive esophagectomy compared to open esophagectomy. To compare both standard outcome measures as well as patient derived outcome measures, in particular, quality of life (QOL). To look at the applicability of this QOL instrument to this patie...
What is the current status of trial NCT00260559?
This trial is currently recruiting. The enrollment target is 3,500 participants. The study started on 1999-05. Estimated completion is 2050-12.
What conditions does trial NCT00260559 study?
This clinical trial studies the following conditions: Esophageal Cancer, Esophagectomy.
What interventions are being tested in trial NCT00260559?
The interventions under investigation include: Questionnaires (PROCEDURE).
Who is sponsoring clinical trial NCT00260559?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00260559 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Esophageal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00260559's enrollment target sits among peer trials
3,500 7th of 123 higher than 117 of 123 other Esophageal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Esophageal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
Registry for Esophageal and Gastroesophageal Junction Cancer
RECRUITING
-
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RECRUITING · Phase 1
-
Retrospective Review of Esophageal Cancer at MSKCC
RECRUITING
-
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
RECRUITING · Phase 1
-
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01612949 · 3,500 participants
Facial Analysis to Classify Difficult Intubation
- NCT02398786 · 3,500 participants
Myotonic Dystrophy Family Registry
- NCT03486873 · 3,500 participants · Phase 3
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
- NCT04831164 · 3,500 participants
Genetic Epidemiology of Rotator Cuff Tears: The cuffGEN Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia